Thermo Fisher Scientific Stock Berne S.E.
Equities
TFS
US8835561023
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
514.5 CHF | -0.35% | -0.35% | +19.58% |
05-10 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
05-10 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 43.01B 39.04B 58.76B | Sales 2025 * | 46.08B 41.83B 62.96B | Capitalization | 225B 205B 308B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.55B 8.35B | Net income 2025 * | 7B 6.36B 9.57B | EV / Sales 2024 * | 5.8 x |
Net Debt 2024 * | 23.99B 21.78B 32.78B | Net Debt 2025 * | 19.18B 17.42B 26.21B | EV / Sales 2025 * | 5.31 x |
P/E ratio 2024 * |
37.3
x | P/E ratio 2025 * |
31.8
x | Employees | - |
Yield 2024 * |
0.25% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | -0.35% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.76% | 186B | |
+12.90% | 135B | |
+25.95% | 107B | |
+0.46% | 63.56B | |
+5.62% | 51.32B | |
+11.08% | 51.04B | |
+6.28% | 43.3B | |
+4.80% | 36.99B | |
+26.67% | 32.01B |
- Stock Market
- Equities
- TMO Stock
- TFS Stock